High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
Oppermann S., Ylanko J., Shi Y., Hariharan S., Oakes C.C., Brauer P.M., Zuniga-Pflucker J.C., Leber B., Spaner D.E., and Andrews, D.W.
(2016). Blood. 128(7):934-947